MIM
RMD icon

Manitou Investment Management’s ResMed RMD Stock Holding History

Manitou Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,000
Closed -$213K – 47
2020
Q4 		$213K Buy
+1,000
New +$199K 0.05% 44
2020
Q1 		– Sell
-2,000
Closed -$310K – 44
2019
Q4 		$310K Hold
2,000
– – 0.07% 36
2019
Q3 		$270K Hold
2,000
– – 0.07% 37
2019
Q2 		$244K Sell
2,000
-1,000
-33% -$111K 0.06% 38
2019
Q1 		$312K Hold
3,000
– – 0.08% 37
2018
Q4 		$302K Hold
3,000
– – 0.07% 35
2018
Q3 		$346K Buy
+3,000
New +$329K 0.09% 34

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Manitou Investment Management's RMD Position: Q1 2021 in Review

Manitou Investment Management sold out of ResMed (RMD) in Q1 2021, closing a stake of 1,000 shares — an estimated $213K sold.

Manitou Investment Management first reported a position in RMD in Q3 2018 and held it in 7 quarters. The position peaked at $346K in Q3 2018. 662 funds tracked by Wall St. Rank hold RMD as of Q1 2021.

  • Manitou Investment Management reported no remaining ResMed position as of Q1 2021 after selling out during the quarter.
  • Manitou Investment Management sold 1,000 ResMed shares in Q1 2021, an estimated $213K.
  • Manitou Investment Management first reported a position in ResMed in Q3 2018 and held it in 7 quarters.
  • Manitou Investment Management's ResMed position peaked at $346K in Q3 2018.
  • 662 funds tracked by Wall St. Rank held ResMed as of Q1 2021.

Based on Manitou Investment Management's 13F filing for Q1 2021, filed 11 May 2021.